Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 270

1.

Response to Acquavella J, conflict of interest: a hazard for epidemiology.

Soskolne CL, Advani S, Sass J, Bero LA, Ruff K.

Ann Epidemiol. 2019 Jul 16. pii: S1047-2797(19)30293-5. doi: 10.1016/j.annepidem.2019.07.010. [Epub ahead of print] No abstract available.

PMID:
31401133
2.

Private food safety standards in the global food supply chain: a scoping review protocol.

Trevena H, Reeve B, Bero L, Thow AM.

JBI Database System Rev Implement Rep. 2019 Aug 5. doi: 10.11124/JBISRIR-D-19-00006. [Epub ahead of print]

PMID:
31389853
3.

Conflicts of interest between the sugary food and beverage industry and dental research organisations: time for reform.

Kearns CE, Bero LA.

Lancet. 2019 Jul 20;394(10194):194-196. doi: 10.1016/S0140-6736(19)31277-2. No abstract available.

PMID:
31327353
4.

Understanding the Nature and Extent of Pharmaceutical Industry Payments to Nonphysician Clinicians.

Karanges EA, Grundy Q, Bero L.

JAMA Intern Med. 2019 Jun 10. doi: 10.1001/jamainternmed.2019.1371. [Epub ahead of print] No abstract available.

PMID:
31180446
5.

Association of industry ties with outcomes of studies examining the effect of wholegrain foods on cardiovascular disease and mortality: systematic review and meta-analysis.

Chartres N, Fabbri A, McDonald S, Turton J, Allman-Farinelli M, McKenzie J, Bero L.

BMJ Open. 2019 May 19;9(5):e022912. doi: 10.1136/bmjopen-2018-022912.

6.

Making nutrition guidelines fit for purpose.

Bero LA, Norris SL, Lawrence MA.

BMJ. 2019 Apr 16;365:l1579. doi: 10.1136/bmj.l1579. No abstract available.

PMID:
30992263
7.

Commercial interests, transparency, and independence: a call for submissions.

Moynihan R, Macdonald H, Heneghan C, Bero L, Godlee F.

BMJ. 2019 Apr 16;365:l1706. doi: 10.1136/bmj.l1706. No abstract available.

PMID:
30992258
8.

The "Hot Potato" of Mental Health App Regulation: A Critical Case Study of the Australian Policy Arena.

Parker L, Bero L, Gillies D, Raven M, Grundy Q.

Int J Health Policy Manag. 2018 Dec 16;8(3):168-176. doi: 10.15171/ijhpm.2018.117.

9.

Medical donations are not always free: an assessment of compliance of medicine and medical device donations with World Health Organization guidelines (2009-2017).

McDonald S, Fabbri A, Parker L, Williams J, Bero L.

Int Health. 2019 Mar 21. pii: ihz004. doi: 10.1093/inthealth/ihz004. [Epub ahead of print]

PMID:
30916303
10.

Data sharing practices of medicines related apps and the mobile ecosystem: traffic, content, and network analysis.

Grundy Q, Chiu K, Held F, Continella A, Bero L, Holz R.

BMJ. 2019 Mar 20;364:l920. doi: 10.1136/bmj.l920.

11.

Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories.

Moynihan R, Lai A, Jarvis H, Duggan G, Goodrick S, Beller E, Bero L.

BMJ Open. 2019 Feb 5;9(2):e025864. doi: 10.1136/bmjopen-2018-025864.

12.

Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study.

Parker L, Karanges EA, Bero L.

BMJ Open. 2019 Feb 19;9(2):e024928. doi: 10.1136/bmjopen-2018-024928.

13.

Design characteristics and statistical methods used in interrupted time series studies evaluating public health interventions: protocol for a review.

Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Cheng AC, Bero L, McKenzie JE.

BMJ Open. 2019 Jan 28;9(1):e024096. doi: 10.1136/bmjopen-2018-024096.

14.

The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures.

Bero L, Chartres N, Diong J, Fabbri A, Ghersi D, Lam J, Lau A, McDonald S, Mintzes B, Sutton P, Turton JL, Woodruff TJ.

Syst Rev. 2018 Dec 21;7(1):242. doi: 10.1186/s13643-018-0915-2.

15.

A review of methods used for hazard identification and risk assessment of environmental hazards.

Chartres N, Bero LA, Norris SL.

Environ Int. 2019 Feb;123:231-239. doi: 10.1016/j.envint.2018.11.060. Epub 2018 Dec 8. Review.

16.

Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors.

Rasmussen K, Bero L, Redberg R, Gøtzsche PC, Lundh A.

BMJ. 2018 Oct 3;363:k3654. doi: 10.1136/bmj.k3654. Erratum in: BMJ. 2018 Oct 11;363:k4298.

17.

The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review.

Fabbri A, Lai A, Grundy Q, Bero LA.

Am J Public Health. 2018 Nov;108(11):e9-e16. doi: 10.2105/AJPH.2018.304677. Epub 2018 Sep 25.

18.

Philip Morris International-funded 'Foundation for a Smoke-Free World': analysing its claims of independence.

van der Eijk Y, Bero LA, Malone RE.

Tob Control. 2018 Sep 21. pii: tobaccocontrol-2018-054278. doi: 10.1136/tobaccocontrol-2018-054278. [Epub ahead of print]

PMID:
30242044
19.

Food industry sponsorship of academic research: investigating commercial bias in the research agenda.

Fabbri A, Holland TJ, Bero LA.

Public Health Nutr. 2018 Dec;21(18):3422-3430. doi: 10.1017/S1368980018002100. Epub 2018 Aug 30.

PMID:
30157979
20.

Industry sponsorship and research outcome: systematic review with meta-analysis.

Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L.

Intensive Care Med. 2018 Oct;44(10):1603-1612. doi: 10.1007/s00134-018-5293-7. Epub 2018 Aug 21. Review.

PMID:
30132025
21.

Mental Health Messages in Prominent Mental Health Apps.

Parker L, Bero L, Gillies D, Raven M, Mintzes B, Jureidini J, Grundy Q.

Ann Fam Med. 2018 Jul;16(4):338-342. doi: 10.1370/afm.2260.

22.

Conflicts of Interest in Nutrition Research.

Bero L, Grundy Q.

JAMA. 2018 Jul 3;320(1):93-94. doi: 10.1001/jama.2018.5662. No abstract available.

PMID:
29971390
23.

Interpreting evidence in general practice: Bias and conflicts of interest.

Parker L, Grundy Q, Bero L.

Aust J Gen Pract. 2018 Jun;47(6):337-340.

24.

Ten tips for spotting industry involvement in science policy.

Bero L.

Tob Control. 2019 Jan;28(1):1-2. doi: 10.1136/tobaccocontrol-2018-054386. Epub 2018 Jun 25. No abstract available.

PMID:
29941543
25.

Reporting bias in the literature on the associations of health-related behaviors and statins with cardiovascular disease and all-cause mortality.

de Rezende LFM, Rey-López JP, de Sá TH, Chartres N, Fabbri A, Powell L, Stamatakis E, Bero L.

PLoS Biol. 2018 Jun 18;16(6):e2005761. doi: 10.1371/journal.pbio.2005761. eCollection 2018 Jun.

26.

The advantages and limitations of guideline adaptation frameworks.

Wang Z, Norris SL, Bero L.

Implement Sci. 2018 May 29;13(1):72. doi: 10.1186/s13012-018-0763-4.

27.

Ethical drug marketing criteria for the 21st century.

Parker L, Williams J, Bero L.

BMJ. 2018 Apr 30;361:k1809. doi: 10.1136/bmj.k1809. Review. No abstract available.

PMID:
29712644
28.

Not All Influences on Science Are Conflicts of Interest.

Bero LA, Grundy Q.

Am J Public Health. 2018 May;108(5):632-633. doi: 10.2105/AJPH.2018.304334. No abstract available.

PMID:
29617619
29.

Meta-research matters: Meta-spin cycles, the blindness of bias, and rebuilding trust.

Bero L.

PLoS Biol. 2018 Apr 2;16(4):e2005972. doi: 10.1371/journal.pbio.2005972. eCollection 2018 Apr.

30.

Essential medicines availability is still suboptimal in many countries: a scoping review.

Mahmić-Kaknjo M, Jeličić-Kadić A, Utrobičić A, Chan K, Bero L, Marušić A.

J Clin Epidemiol. 2018 Jun;98:41-52. doi: 10.1016/j.jclinepi.2018.02.006. Epub 2018 Feb 13. Review.

PMID:
29452222
31.

Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over-active bladder syndrome? An Australian cohort study.

Mintzes B, Swandari S, Fabbri A, Grundy Q, Moynihan R, Bero L.

BMJ Open. 2018 Feb 13;8(2):e019027. doi: 10.1136/bmjopen-2017-019027.

32.

An analysis of methods used to synthesize evidence and grade recommendations in food-based dietary guidelines.

Blake P, Durão S, Naude CE, Bero L.

Nutr Rev. 2018 Apr 1;76(4):290-300. doi: 10.1093/nutrit/nux074.

33.

Prevalence of Disclosed Conflicts of Interest in Biomedical Research and Associations With Journal Impact Factors and Altmetric Scores.

Grundy Q, Dunn AG, Bourgeois FT, Coiera E, Bero L.

JAMA. 2018 Jan 23;319(4):408-409. doi: 10.1001/jama.2017.20738. No abstract available.

34.

Improving the Use of Research Evidence in Guideline Development [Internet].

Oxman AD, Schünemann HJ, Fretheim A, Boyd EA, Bero LA, Tan-Torres Edejer T.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2007 Mar.

35.

Getting the systematic review basics right helps clinical practice: 4 common pitfalls for systematic review authors to avoid.

Bero L.

Br J Sports Med. 2019 Jan;53(1):6-8. doi: 10.1136/bjsports-2017-098239. Epub 2017 Dec 7. No abstract available.

PMID:
29217534
36.

Developing reliable dietary guidelines.

Bero L.

BMJ. 2017 Nov 3;359:j4845. doi: 10.1136/bmj.j4845. No abstract available.

PMID:
29101096
37.

A Social Network Analysis of the Financial Links Backing Health and Fitness Apps.

Grundy Q, Held F, Bero L.

Am J Public Health. 2017 Nov;107(11):1783-1788. doi: 10.2105/AJPH.2017.303995. Epub 2017 Sep 21.

PMID:
28933939
38.

'Spin' in published biomedical literature: A methodological systematic review.

Chiu K, Grundy Q, Bero L.

PLoS Biol. 2017 Sep 11;15(9):e2002173. doi: 10.1371/journal.pbio.2002173. eCollection 2017 Sep. Review.

39.

Study sponsorship and the nutrition research agenda: analysis of cohort studies examining the association between nutrition and obesity.

Fabbri A, Chartres N, Bero LA.

Public Health Nutr. 2017 Dec;20(17):3193-3199. doi: 10.1017/S1368980017002178. Epub 2017 Aug 30.

PMID:
28851466
40.

A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia.

Fabbri A, Grundy Q, Mintzes B, Swandari S, Moynihan R, Walkom E, Bero LA.

BMJ Open. 2017 Jun 30;7(6):e016701. doi: 10.1136/bmjopen-2017-016701.

41.

Tracing the Potential Flow of Consumer Data: A Network Analysis of Prominent Health and Fitness Apps.

Grundy Q, Held FP, Bero LA.

J Med Internet Res. 2017 Jun 28;19(6):e233. doi: 10.2196/jmir.7347.

42.

Medicine shortages in Fiji: A qualitative exploration of stakeholders' views.

Walker J, Chaar BB, Vera N, Pillai AS, Lim JS, Bero L, Moles RJ.

PLoS One. 2017 Jun 5;12(6):e0178429. doi: 10.1371/journal.pone.0178429. eCollection 2017.

43.

Conflicts of Interest and the Presence of Methodologists on Guideline Development Panels: A Cross-Sectional Study of Clinical Practice Guidelines for Major Depressive Disorder.

Cosgrove L, Shaughnessy AF, Peters SM, Lexchin JR, Bursztajn H, Bero L.

Psychother Psychosom. 2017;86(3):168-170. doi: 10.1159/000458727. Epub 2017 May 11. No abstract available.

PMID:
28490018
44.

Addressing Bias and Conflict of Interest Among Biomedical Researchers.

Bero L.

JAMA. 2017 May 2;317(17):1723-1724. doi: 10.1001/jama.2017.3854. No abstract available.

PMID:
28464166
45.

Interpretation and use of evidence in state policymaking: a qualitative analysis.

Apollonio DE, Bero LA.

BMJ Open. 2017 Feb 20;7(2):e012738. doi: 10.1136/bmjopen-2016-012738.

46.

Industry sponsorship and research outcome.

Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L.

Cochrane Database Syst Rev. 2017 Feb 16;2:MR000033. doi: 10.1002/14651858.MR000033.pub3. Review.

PMID:
28207928
47.

Toward a Healthier Patient Voice: More Independence, Less Industry Funding.

Moynihan R, Bero L.

JAMA Intern Med. 2017 Mar 1;177(3):350-351. doi: 10.1001/jamainternmed.2016.9179. No abstract available.

PMID:
28114596
48.

The ties that bind.

Lundh A, Bero L.

BMJ. 2017 Jan 17;356:j176. doi: 10.1136/bmj.j176. No abstract available.

PMID:
28096082
49.

Why Having a (Nonfinancial) Interest Is Not a Conflict of Interest.

Bero LA, Grundy Q.

PLoS Biol. 2016 Dec 21;14(12):e2001221. doi: 10.1371/journal.pbio.2001221. eCollection 2016 Dec.

50.

Study sponsorship and the nutrition research agenda: analysis of randomized controlled trials included in systematic reviews of nutrition interventions to address obesity.

Fabbri A, Chartres N, Scrinis G, Bero LA.

Public Health Nutr. 2017 May;20(7):1306-1313. doi: 10.1017/S1368980016003128. Epub 2016 Dec 19. Review.

PMID:
27989264

Supplemental Content

Support Center